Takeda Provides Updates on Its Pharmacokinetic-guided Prophylaxis Studies at ISTH 2020, Reinforcing Its Commitment to Advancing Personalized Care for People with Bleeding Disorders

OSAKA, Japan — (BUSINESS WIRE) — Takeda Pharmaceutical Company Limited (「Takeda」) (TSE: 4502/NYSE:TAK) today announced that 13 abstracts are being presented from the company』s Hematology p…